Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib

Authors

  • Koji Miyahara M.D.,

    1. Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
    Search for more papers by this author
  • Kazuhiro Nouso M.D., Ph.D.,

    1. Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
    2. Department of Molecular Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
    Search for more papers by this author
  • Yasuhiro Miyake M.D., Ph.D.,

    1. Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
    Search for more papers by this author
  • Shinichiro Nakamura M.D., Ph.D.,

    1. Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
    Search for more papers by this author
  • Shuntaro Obi M.D., Ph.D.,

    1. Division of Hepatology, Kyoundo Hospital, Tokyo, Japan
    Search for more papers by this author
  • Maho Amano Ph.D.,

    1. Field of Drug Discovery Research, Faculty of Advanced Life Science & Graduate School of Life Science, Hokkaido University, Sapporo, Japan
    2. Medicinal Chemistry Pharmaceuticals, Sapporo, Japan
    Search for more papers by this author
  • Kazuko Hirose Ph.D.,

    1. Field of Drug Discovery Research, Faculty of Advanced Life Science & Graduate School of Life Science, Hokkaido University, Sapporo, Japan
    Search for more papers by this author
  • Shin-Ichiro Nishimura Ph.D.,

    1. Field of Drug Discovery Research, Faculty of Advanced Life Science & Graduate School of Life Science, Hokkaido University, Sapporo, Japan
    2. Medicinal Chemistry Pharmaceuticals, Sapporo, Japan
    Search for more papers by this author
  • Kazuhide Yamamoto M.D., Ph.D.

    1. Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
    Search for more papers by this author

  • Supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI 23590976) and partly by a grant for “Development of Systems and Technology for Advanced Measurement and Analysis (SENTAN)” and “The Matching Program for Innovations in Future Drug Discovery and Medical Care” from the Japan Science and Technology Agency and the Ministry of Education, Culture, Science, and Technology, Japan.

  • Potential conflict of interest: Dr. Yamamoto received grants from Bayer Yakuhin.

No abstract is available for this article.

Ancillary